BIO NEWSLETTER: Biotech Insights from Korea (Issue 4)

ISSUE #4 June 25, 2025

📚 Browse Past Issues

Thank you for joining us at BIO 2025!

KoreaBIO successfully operated the largest-ever Korean National Pavilion

in its 22-year history during BIO 2025!

Check Out in BIOTECH TV!

BIO International 2025:

An intro to the BIO International Convention, and stopping by the Korea Pavilion

World's most tangible Bio-Healthcare convention!

BIOPLUS INTERPHEX KOREA 2025

October 15-17, 2025

South Korean Biotech Command Global Spotlight at BIO 2025 with Dynamic Pavilion & Strategic Alliances

South Korean biotechnology companies marked a significant presence at the BIO International Convention 2025, held in Boston. June 23, 2025· via [GeneOnline]

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA®, expanding dosing options for pediatric patients

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA®, a biosimilar to STELARA®, in a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection.

June 16, 2025· via [The Korea Herald]

Lunit AI Used Again for Mass Screening During 2025 Hajj Season in Saudi Arabia

Saudi Government and Seha Virtual Hospital selected Lunit INSIGHT CXR to detect respiratory diseases among millions of pilgrims, supporting Saudi Arabia’s Vision 2030 healthcare strategy

June 13, 2025· via [The BIO]

SK, Hanwha, and Daesang drive growth in Korean cultured meat industry

Korean companies pivot towards innovative protein sources, focusing on cell cultivation to combat climate challenges.

June 19, 2025· via [ChosunBiz]

GS Caltex mulls palm oil waste recycling business in Indonesia

GS Caltex Corp., South Korea's second-largest refiner by sales, said Tuesday it is considering producing biofuel by recycling waste from palm oil mills in Indonesia.

June 24, 2025· via [Yonhap News Agency]

∎ Korean Delegation Steals Spotlight at BIO USA 2025 (PharmEdaily)

∎ Korea Bio opens largest national pavilion at Bio USA 2025 (The Korea Herald)
∎ K-Bio showcases in Boston, the U.S. Bio hub…“Pursuing global partnership expansion” (THE BIO)
∎ Global biotech leaders call for stronger, smarter supply chains (The Korea Herald)
∎ CDMO, New Drugs, and Organoids: Korea’s Biotech Strategy Unfolds at BIO USA (The Korea Bizwire)
∎ GI Innovation introduces the first ‘trispecific antibody,’ advancing beyond ‘aPD-L1xVEGF’ dual antibody (THE BIO)
∎ Dong-A ST unveils next-gen oncology/immunology pipeline, expands global outreach (KBR)
∎ Samsung Biologics expands strategic focus to top 40 global pharma (The Korea Herald)
∎ Celltrion advances global expansion with 150+ partnership talks (KBR)

∎ Celltrion biosimilars expand dominance in Japan's oncology market (PharmEdaily)
∎ Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics (BioSpace)
∎ Noul inks $520K Italy deal with TEMA RICERCA to expand AI blood diagnostics (KBR)
∎ GI Innovation secures U.S. patent for 'GI-301' sialic acid…Expands protection to include quality standards (THE BIO)
∎ Yuhan secures US patent for lung cancer drug lazertinib, blocking copycats (KBR)
∎ HurayPositive, Xlife Sciences, and oncoMASTER form alliance for digital health and precision medicine (THE BIO)

∎ Samsung Biologics launches organoid platform to boost early-stage drug discovery (The Korea Herald)
∎ Galax and Hanall Bio collaborate to develop AI-driven cancer antibody drug (ChosunBiz)
∎ Celltrion and Onconic team up on ovarian cancer combo with dual-target PARP drug (KBR)
∎ Blood tests may replace colonoscopy for colorectal cancer screening in Korea (KBR)
∎ Yuhan’s allergy drug shows promise for patients unresponsive to Xolair (Pluse)
∎ Binex inks new Celltrion deal to make clinical-stage biosimilars (KBR)
∎ Korea's Mezzion expands Udenafil pipeline to target multi-billion dollar kidney disease market (BioSpectrum Asia)
∎ STGEN Bio secures ₩9.8 bil. biopharmaceutical CMO deal (KBR)

∎ Taekwang Industry Launches Eco-Friendly Plant-Based Nylon Yarn, ACECOOL-BIO (Chemanalyst News)

∎ Bell Therapeutics’ Digital Insomnia Therapeutic Gains Innovative Medical Device Status (Business Korea)

★ BIOPLUS-INTERPHEX KOREA 2025 Sets the Stage for Regional Bio Leadership with Launch of Asia Bio Connect (Business News This Week)

[Who We Are] KoreaBIO in Text!

[SHORTS] Inside the Biggest Korea Pavilion at BIO 2025 👀

Join our press list

Get KoreaBIO updates
& media resources

Share Your thoughts!

How was your letter today?

Korean Newsletter

Daily biotech news from Korea and around the world
— in Korean

Stay connected with everything

Watch and Join!

KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea

+82-31-628-0037
수신거부 Unsubscribe